Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

53.87
-1.2900-2.34%
Post-market: 53.870.00000.00%19:30 EDT
Volume:336.19K
Turnover:18.33M
Market Cap:1.60B
PE:-59.54
High:56.32
Open:55.43
Low:53.75
Close:55.16
52wk High:73.30
52wk Low:17.11
Shares:29.61M
Float Shares:21.05M
Volume Ratio:0.55
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9047
EPS(LYR):-0.4601
ROE:-114.55%
ROA:6.78%
PB:125.13
PE(LYR):-117.08

Loading ...

AnaptysBio price target lowered to $60 from $90 at UBS

TIPRANKS
·
Apr 22

UBS Adjusts Price Target on AnaptysBio to $60 From $90, Maintains Buy Rating

MT Newswires Live
·
Apr 22

AnaptysBio Is Maintained at Buy by UBS

Dow Jones
·
Apr 22

AnaptysBio price target lowered to $60 from $90 at UBS

TIPRANKS
·
Apr 21

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Apr 21

AnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge

MT Newswires Live
·
Apr 20

Anaptys Completes Separation of First Tracks Biotherapeutics and NOW Exclusively Manages GSK and Vanda Financial Collaborations

THOMSON REUTERS
·
Apr 20

AnaptysBio completes spin-off of First Tracks Biotherapeutics in corporate reorganization

Reuters
·
Apr 20

Trade Alert: Independent Director Of AnaptysBio John Schmid Has Sold Stock

Simply Wall St.
·
Apr 08

Assessing AnaptysBio (ANAB) Valuation After New Share Buyback Plan And Canceled Equity Offering

Simply Wall St.
·
Apr 06

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

TIPRANKS
·
Apr 04

AnaptysBio files Form 3 for director Susannah Gray, reporting no securities owned

Reuters
·
Apr 04

AnaptysBio director John P. Schmid disposes shares worth $1.1 million

Reuters
·
Apr 02

AnaptysBio Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Apr 01

U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks

Reuters
·
Mar 31

AnaptysBio Price Target Maintained With a $66.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 30

AnaptysBio Spin Off Reshapes Risk Profile With New Royalty Focus

Simply Wall St.
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

BUZZ-AnaptysBio falls after board approves First Tracks Biotherapeutics spinoff

Reuters
·
Mar 27

AnaptysBio announces $100M share repurchase program

TIPRANKS
·
Mar 27